MicroCT Liver Contrast Agent Enhancement Over Time, Dose, and Mouse Strain
- 326 Downloads
The aim of this study was to examine strain differences in the uptake of Fenestra liver contrast agent (LC) in Nude, C57, and severe-combined immunodeficient (SCID) mice. In addition, we aimed to determine optimum dosing and to determine if there are positron emission tomography (PET)-attenuation effects on 2-deoxy-2[F-18]fluoro-d-glucose (FDG) values due to Fenestra LC.
Nude, C57, and SCID mice were injected via tail vein at 5.0, 7.5, 10.0, and 15.0 ml/kg with contrast agent and imaged using micro computed tomography (microCT) 2 h after uptake and then daily up to 7 days. Mice were imaged by microPET/CT with FDG, with or without contrast agent.
Significant variations in contrast were observed between mouse strains. SCID mice had significantly more spleen uptake of contrast than the other strains, and C57 mice had significantly more liver uptake of contrast than other strains. Across all strains, the spleen showed significantly higher uptake and duration of contrast than liver. Only the heart showed a significant attenuation of FDG uptake following contrast administration.
Strain-specific variations in Fenestra LC uptake and signal duration were observed. At 7.5 ml/kg, this contrast agent is effective for imaging for 1 day, whereas at 15 ml/kg, it can be used up to 1 week. Fenestra LC does not appear to attenuate FDG uptake at 15 ml/kg for most tissues; therefore, it can be used in conjunction with microPET imaging studies.
Key wordsLiver contrast agent MicroCT MicroPET SCID mice Nude mice C57BL/6 mice CT contrast agent
- 1.Alerion Biomedical (2007) Fenestra LC User Guide # LC-101-IT; Hepatic Imaging in Balb/c Mice: Visualization of Hepatic Focal Lesions and Anatomy Using a MicroCAT II (Imtek) ScannerGoogle Scholar
- 7.Shimizu S (2004) Routes of Administration. In: Hendrich H (ed) The laboratory mouse. Elsevier Academic, New York, pp 527–542Google Scholar
- 8.ART Advanced Research Technologies (2007) Tips For Great Results With Fenestra Contrast Agents. www.art.ca
- 13.Bakan DA, Longino MA, Weichert JP, Counsell RE (1996) Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography. J Pharm Sci 85:908–914PubMedCrossRefGoogle Scholar
- 14.Croy AC, DiSanto JP, Manz M, et al. (2007) Mouse models of immunodeficiency. In: Fox JG, Barthold SW, Davisson MT et al. (eds) The mouse in biomedical research. Elsevier, New York, p 275–289Google Scholar
- 16.Jacoby RO, Fox JG, Davisson M (2002) Biology and diseases of mice. In: Fox JG, Anderson LC, Loew FM et al. (eds) Laboratory animal medicine, 2nd Edition. Elsevier Science, New York, pp 35–120Google Scholar